Comparative Pharmacology
Head-to-head clinical analysis: DEXTROSE 5 SODIUM CHLORIDE 0 33 AND POTASSIUM CHLORIDE 20MEQ IN PLASTIC CONTAINER versus MAGNESIUM SULFATE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DEXTROSE 5 SODIUM CHLORIDE 0 33 AND POTASSIUM CHLORIDE 20MEQ IN PLASTIC CONTAINER versus MAGNESIUM SULFATE.
DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 20MEQ IN PLASTIC CONTAINER vs MAGNESIUM SULFATE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Dextrose is a monosaccharide that provides calories and serves as a source of glucose for cellular metabolism. Sodium chloride and potassium chloride are electrolytes that restore and maintain fluid and electrolyte balance. Potassium is essential for nerve conduction, muscle contraction, and acid-base balance. Sodium is the main cation of extracellular fluid and regulates fluid balance, while chloride is the main anion.
Magnesium sulfate acts as a physiological calcium channel blocker. It inhibits calcium influx into presynaptic nerve terminals, reducing acetylcholine release at the neuromuscular junction and decreasing muscle contraction. It also antagonizes NMDA receptors and stabilizes neuronal membranes.
Intravenous infusion; adult dose determined by fluid, electrolyte, and caloric needs. Typical administration rate: 1-2 liters per day at 100-200 mL/hour, not to exceed 0.5 g/kg/hour dextrose and 0.5 mEq/kg/hour potassium. Maximum potassium infusion rate: 10 mEq/hour (or 0.5 mEq/kg/hour).
IV: Loading dose 4-6 g over 20-30 minutes, followed by maintenance infusion 1-2 g/hour for seizure prophylaxis in severe preeclampsia/eclampsia. IM: 4-8 g deep IM initially, then 4 g every 4 hours as needed.
None Documented
None Documented
Glucose: ~30 minutes (metabolic clearance). Potassium: distribution half-life 1 hour, elimination half-life ~12 hours (renal-dependent). Sodium/chloride: rapidly equilibrated, with elimination half-life determined by renal function.
Terminal elimination half-life approximately 4-6 hours in patients with normal renal function; prolonged to 12-24 hours or more in renal impairment, necessitating dose adjustment
Electrolytes (sodium, chloride, potassium) are primarily excreted renally; glucose is metabolized to CO2 and water, with minimal renal excretion of unchanged glucose (<1% in normoglycemia). Biliary/fecal elimination is negligible for individual components.
Primarily renal (90-95% as unchanged drug); minor biliary/fecal (<5%)
Category A/B
Category C
Electrolyte
Electrolyte